Sunday, June 4, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – April 20, 2014

by Global Biodefense Staff
April 20, 2014

Biosurveillance measures bulking up | Study: Growing Guinea outbreak caused by new Ebola strain | New nasal spray offers hope in fighting a flu epidemic | Will pre-alerting responders cut emergency response times? | Saudis report 12 more MERS cases; Greece has its first | Rearming penicillin for the twenty-first century | Measles on a cruise ship: Links with the outbreak in the Philippines | Ebola drug could be ready for human testing next year | BIO calls for adequate funding of vaccine and biodefense programs | Boston debates banning deadliest pathogens from new biolab | Stockpiles of Roche Tamiflu drug are waste of money, review finds | Identifying the most likely non-state chem-bio threats | CDC sees little overall progress on foodborne infections | Guidance for evacuees in disaster zones inspired by ant colonies | New antiviral drug to combat measles outbreaks

See what we’re reading this week at Global Biodefense on topics like the new antiviral drug for measles, MERS-CoV spreading to Europe, Boston high-containment lab controversies and more…

Biosurveillance measures bulking up (Armed with Science)

Study: Growing Guinea outbreak caused by new Ebola strain (CIDRAP)

Saudis report 12 more MERS cases; Greece has its first (CIDRAP)

Rearming penicillin for the twenty-first century (HSNW)

Measles on a cruise ship: Links with the outbreak in the Philippines (Eurosurveillance)

Ebola drug could be ready for human testing next year (NPR)

BIO calls for adequate funding of vaccine and biodefense programs (BIOtech Now)

Boston debates banning deadliest pathogens from new biolab (NTI GSN)

Stockpiles of Roche Tamiflu drug are waste of money, review finds (Reuters)

Identifying the most likely non-state chem-bio threats (HSNW)

CDC sees little overall progress on foodborne infections (CIDRAP)

Guidance for evacuees in disaster zones inspired by ant colonies (MNT)

Related Posts

Biodefense Headlines – 25 April 2023
News Scan

Biodefense Headlines – 25 April 2023

April 25, 2023
Biodefense Headlines – 9 April 2023
News Scan

Biodefense Headlines – 9 April 2023

April 9, 2023
News Scan

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC